Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2005; 11(22): 3446-3450
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3446
Figure 3
Figure 3 Treatment of SGC-7901 tumor-bearing mice with SGC-7901+FasL cells. A: Mice were injected with SGC-7901 cells (5×105), followed by treatment with FasL (n = 8); B: mice were injected with SGC-7901 cells (5×105); C: mice were injected with SGC-7901 cells (5×105), followed by treatment with PBS (n = 8). Tumor incidence is presented at each time point in Figure. P<0.0001.